Geneva Partners, LLC Bio Techne Corp Transaction History
Geneva Partners, LLC
- $229 Million
- Q3 2024
Shares
2 transactions
Others Institutions Holding TECH
# of Institutions
601Shares Held
151MCall Options Held
195KPut Options Held
53.2K-
Vanguard Group Inc Valley Forge, PA18.3MShares$1.31 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY15MShares$1.07 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD9.42MShares$672 Million0.09% of portfolio
-
State Street Corp Boston, MA6.4MShares$456 Million0.02% of portfolio
-
Morgan Stanley New York, NY4.66MShares$332 Million0.03% of portfolio
About BIO-TECHNE Corp
- Ticker TECH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,222,600
- Market Cap $2.8B
- Description
- Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...